Tokyo, Feb. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060509) titled 'Role of background metformin therapy in cardiorenal outcomes in type 2 diabetic patients treated with SGLT2 inhibitors' on Feb. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Bay Urayasu Ichikawa Medical Center
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify whether background antidiabetic therapy, especially Metformin, modifies the cardiovascular and renal protective effects of SGLT2 inhibitors
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applica...